An observational, retrospective study assessing safety and efficacy of dimethyl fumarate in patients with relapsing remitting multiple sclerosis

Trial Profile

An observational, retrospective study assessing safety and efficacy of dimethyl fumarate in patients with relapsing remitting multiple sclerosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Dimethyl fumarate (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 16 Nov 2016 New trial record
    • 17 Sep 2016 Results assessing safety and efficacy presented at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top